Pure Biologics

Pure Biologics Depreciation & Amortization

The Depreciation & Amortization of Pure Biologics (PUR.WA) as of Nov 12, 2026 is 309,000.00 PLN. In the previous year, Depreciation & Amortization was 5.78 M PLN — a change of -94.66% (lower).

Depreciation & Amortization

309,000.00PLN

YoY

-94.66%

Last updated:

Depreciation & Amortization of Pure Biologics is 2024 309,000.00 PLN. Depreciation & Amortization of Pure Biologics was 2023 5.78 M PLN. It decreases by -94.66% lower compared to the previous year.

The Pure Biologics Depreciation & Amortization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Depreciation & Amortization
Date
Depreciation & Amortization
Jan 1, 2016
48,700.00 PLN
Jan 1, 2017
104,300.00 PLN
Jan 1, 2018
210,700.00 PLN
Jan 1, 2019
732,200.00 PLN
Jan 1, 2021
2.92 M PLN
Jan 1, 2022
2.50 M PLN
Jan 1, 2023
5.78 M PLN
Jan 1, 2024
309,000.00 PLN
The Pure Biologics Depreciation & Amortization history
YEARDepreciation & AmortizationYoY
309,000.00PLN-94.66%
5.78 MPLN+131.64%
2.50 MPLN-14.49%
2.92 MPLN+298.80%
732,200.00PLN+247.51%
210,700.00PLN+102.01%
104,300.00PLN+114.17%
48,700.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics SA, headquartered in Wrocław, Poland, operates in the Health Care sector as a biotechnology company. It focuses on research and development of innovative biological medicines and medical devices for therapeutic and diagnostic applications. The company employs 53 full-time staff and was listed on the stock market on 11 December 2018. Founded in August 2010, it remains based in Wrocław, focusing on biopharmaceutical solutions. Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

Depreciation & Amortization of Pure Biologics is 309,000.00 PLN in 2024.

Depreciation & Amortization of Pure Biologics changed from 5.78 M PLN to 309,000.00 PLN, representing a -94.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Depreciation & Amortization Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

Depreciation & Amortization represents the allocation of the cost of tangible and intangible assets over their useful lives.

Depreciation & Amortization's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Depreciation & Amortization's Pure Biologics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Pure Biologics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Pure Biologics